Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 34

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 34
---
 entity has a class of common equity securities listed on the NYSE, the NYSE American 
 or Nasdaq, or listed or quoted on an exchange or quotation system that is a successor to the NYSE, NYSE American or Nasdaq.           |

Notwithstanding the foregoing, if the transaction
or series of transactions described in the first bullet point above (the “Change of Control Transaction”) forms part of a
series of related transactions that are closed or consummated within twelve (12) months of the closing or consummation of the Change of
Control Transaction (including, without limitation, any merger, consolidation, sale or transfer of assets, recapitalization, reorganization,
or special or extraordinary distribution, in each case outside of the ordinary course of our business (the “Related Transactions”)),
and if the aggregate consideration paid to us and/or holders of our common stock in connection with the Change of Control Transaction
represents less than 50.0% of the aggregate consideration payable to us and/or our holders of common stock in connection with both the
Change of Control Transaction and the Related Transaction on a combined basis, then the Change of Control Transaction shall be deemed
to constitute a Change of Control, regardless of whether the second bullet point above is satisfied.

Conversion Right Upon a Change of Control

Upon the occurrence of a Change of Control, each
holder of Series B Preferred Stock will have the right (unless, prior to the Change of Control Conversion Date (as defined below),
we have provided or provide notice of our election to redeem, in whole or in part, the Series B Preferred Stock as described above
under “— Redemption”) to convert some or all of the Series B Preferred Stock held by such holder (the “Change
of Control Conversion Right”), on the Change of Control Conversion Date (as defined below) into a number of shares of our common
stock per share of Series B Preferred Stock to be converted equal to the lesser of:

| · | the quotient obtained by dividing (i) the sum of (x) the liquidation                                                                      
 preference amount of $25.00 per share of Series B Preferred Stock, plus (y) any accrued and unpaid dividends thereon (whether             
 or not declared) to, but excluding, the Change of Control Conversion Date (unless the Change of Control Conversion Date is after a record 
 date for a Series B Preferred Stock dividend payment for which dividends have been declared and prior to the corresponding Series B       
 Preferred Stock dividend payment date, in which case no additional amount for